1219692-88-2Relevant academic research and scientific papers
BENZOFURO[3,2-c] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA
-
Page/Page column 52, (2012/07/28)
The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, methods of preparation, and use thereof. These compounds are useful in the treatment of central nervous system disorders including obesity, metabolic syndrome, cognition, schizophrenia, attention deficit hyperactivity disorder, bipolar disorder, rare and orphan diseases, and sleep disorders. The subject compounds have the structure of formula (I) with the substituents being described herein.
Advanced supramolecular initiator for nitroxide-mediated polymerizations containing both metal-ion coordination and hydrogen-bonding sites
Mansfeld, Ulrich,Hager, Martin D.,Hoogenboom, Richard,Ott, Christina,Winter, Andreas,Schubert, Ulrich S.
supporting information; experimental part, p. 3386 - 3388 (2009/12/26)
The synthesis of a new difunctional nitroxide initiator combining two orthogonal supramolecular entities is reported; controlled radical polymerization of styrene using this initiator is demonstrated to generate well-defined heterotelechelic polymers in a
